Covalon Technologies Ltd. (COV.V)

CAD 3.44

(2.99%)

Long Term Debt Summary of Covalon Technologies Ltd.

  • Covalon Technologies Ltd.'s latest annual long term debt in 2023 was 919.08 Thousand CAD , down -41.05% from previous year.
  • Covalon Technologies Ltd.'s latest quarterly long term debt in 2024 Q3 was 412.68 Thousand CAD , down 0.0% from previous quarter.
  • Covalon Technologies Ltd. reported annual long term debt of 1.55 Million CAD in 2022, down -23.93% from previous year.
  • Covalon Technologies Ltd. reported annual long term debt of 2.04 Million CAD in 2021, down -23.05% from previous year.
  • Covalon Technologies Ltd. reported quarterly long term debt of 588.3 Thousand CAD for 2024 Q2, down 0.0% from previous quarter.
  • Covalon Technologies Ltd. reported quarterly long term debt of 737.32 Thousand CAD for 2024 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Covalon Technologies Ltd. (2023 - 2005)

Historical Annual Long Term Debt of Covalon Technologies Ltd. (2023 - 2005)

Year Long Term Debt Long Term Debt Growth
2023 919.08 Thousand CAD -41.05%
2022 1.55 Million CAD -23.93%
2021 2.04 Million CAD -23.05%
2020 2.66 Million CAD -57.69%
2019 6.29 Million CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD -100.0%
2014 660.51 Thousand CAD 28.0%
2013 516.01 Thousand CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD 0.0%
2005 - CAD 0.0%

Peer Long Term Debt Comparison of Covalon Technologies Ltd.

Name Long Term Debt Long Term Debt Difference
Arch Biopartners Inc. 703.92 Thousand CAD -30.566%
Hemostemix Inc. 4.32 Million CAD 78.732%
Universal Ibogaine Inc. 1.73 Million CAD 47.109%
Kane Biotech Inc. 1.3 Million CAD 29.435%
MedMira Inc. 2.95 Million CAD 68.921%
Marvel Biosciences Corp. 1 Million CAD 8.092%
NervGen Pharma Corp. 105.6 Thousand CAD -770.308%
XORTX Therapeutics Inc. - CAD -Infinity%